Skip to main content
Caplight Logo









NXgenPort

NXgenPort

Private
Saint Paul, MinnesotaHealthcare & Life Scienceshttps://www.nxgenport.com/

Last Round

Seed

Nov 30, 2024

Total Funding Raised

$142,500

Company Overview

NXgenPort is a medical technology company that develops an implantable smart port device designed to provide remote physiological monitoring for cancer patients undergoing chemotherapy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

remote patient monitoringRPMimplantable medical devicesmart chemo-portdigital healthsoftware as a medical deviceSaMDoptical sensorhealthcare analyticswearable health techclinical monitoringconnected medical deviceIoMTinternet of medical thingspredictive oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NXgenPort Comparables

Compare NXgenPort with similar companies based on industry and business-model similarity.

NXgenPort comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PAVmed Inc.
78%
Neomend
71%
ICU Medical Inc
71%

NXgenPort Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 30, 2024
AcceleratorJul 28, 2023
AcceleratorJun 6, 2023
AcceleratorNov 10, 2021

Key People

Founding team and executive leadership

Cathy Skinner

Chief Executive Officer

Executive Team

NXgenPort Investors

Notable investors and investment history

NXgenPort investors
InvestorRounds
MedTech InnovatorAccelerator
CANCER FUNDSeed
Mayo Clinic PlatformAccelerator
mHUBAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 6, 2023

    Received funding from MedTech Innovator.

  • Nov 10, 2021

    $143K raised from mhub and Baxter International

NXgenPort Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NXgenPort Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NXgenPort's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Paul, Minnesota
Employee Range7
Year Founded2020
Last FundingNov 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?